Skip to main content

Advertisement

Table 2 Characteristics of source population (totals for Table 1)

From: Counting drugs to understand the disease: The case of measuring the diabetes epidemic

  Females Males
Year Size P I D 1 D 0 Size P I D 1 D 0
1994 225,159 3,365 416 209 2,446 218,948 3,502 519 256 2,547
1995 225,394 3,464 399 254 2,510 219,296 3,667 469 230 2,593
1996 225,633 3,501 500 207 2,505 219,416 3,780 563 231 2,592
1997 225,949 3,662 418 235 2,471 219,845 4,004 504 242 2,417
1998 227,086 3,761 429 229 2,386 221,198 4,174 571 238 2,406
1999 227,389 3,836 486 226 2,522 221,439 4,396 559 263 2,440
2000 227,510 3,997 521 214 2,423 221,462 4,580 623 239 2,322
2001 227,608 4,212 547 215 2,396 221,593 4,867 641 276 2,307
2002 227,745 4,446 581 241 2,525 221,683 5,131 734 289 2,279
2003 227,840 4,684 656 249 2,363 222,008 5,453 783 292 2,198
  1. Total size of population, prevalence, incidence, and mortality with respect to use of anti-diabetic drugs, Fyn County, Denmark, 1994–2003, cf. Table 1. Size is the size of the population on January 1, 1993–2003, where subjects migrating into the capture area in the preceding year are ignored. P is the count of prevalent subjects at January 1 of the given year. I is the count of incident subjects during the calendar year. D 1 is the count of deaths during the year among subjects prevalent at the beginning of the year. D 0 are deaths among non-prevalents in the year.